Financial Performance - The company's operating revenue for Q3 2023 was ¥112,673,360.34, representing a year-over-year increase of 13.46%[3] - The net profit attributable to shareholders for the same period was ¥18,809,807.50, up 14.88% compared to the previous year[3] - The basic earnings per share for Q3 2023 was ¥0.27, reflecting a 17.39% increase year-over-year[3] - The company reported a net profit growth of 37.46% for the year-to-date, attributed to stable growth in core business areas[7] - Total operating revenue for the first three quarters of 2023 reached CNY 288,588,445.42, an increase of 17.5% compared to CNY 245,570,860.75 in the same period of 2022[19] - Operating profit for the first three quarters of 2023 was CNY 73,585,438.09, up 53.2% from CNY 48,034,799.66 in the first three quarters of 2022[19] - Net profit for Q3 2023 was CNY 63,708,705.72, representing a 50.1% increase from CNY 42,431,872.47 in Q3 2022[20] - Basic earnings per share for Q3 2023 were CNY 0.84, compared to CNY 0.61 in Q3 2022, reflecting a 37.7% increase[20] - The company reported a total profit of CNY 73,377,803.20 for the first three quarters of 2023, an increase of 52.8% compared to CNY 48,034,050.60 in the same period of 2022[19] Cash Flow and Assets - The net cash flow from operating activities for the year-to-date was ¥49,694,277.18, showing a decline of 13.55% year-over-year[3] - Cash flow from operating activities for the first three quarters of 2023 was CNY 49,694,277.18, down 13.1% from CNY 57,484,160.80 in the same period of 2022[24] - Cash flow from investing activities showed a net outflow of CNY 41,384,469.97 in the first three quarters of 2023, compared to a net outflow of CNY 149,257,125.45 in the same period of 2022[25] - Cash and cash equivalents decreased to RMB 67,270,586.17 from RMB 106,229,233.62, a decline of about 36.7%[13] - Cash and cash equivalents at the end of Q3 2023 were CNY 67,270,586.17, down from CNY 76,480,102.70 at the end of Q3 2022[25] Research and Development - Research and development expenses totaled ¥5,024,675.87, accounting for 4.46% of operating revenue, a decrease of 0.03 percentage points from the previous year[4] - Research and development expenses for the first three quarters of 2023 were CNY 15,359,579.82, up 26.5% from CNY 12,182,632.42 in the same period of 2022[19] Assets and Liabilities - The total assets of the company at the end of the reporting period were ¥900,579,759.33, a slight increase of 0.99% from the end of the previous year[4] - As of September 30, 2023, the company's total assets amounted to RMB 900,579,759.33, an increase from RMB 891,727,828.65 at the end of 2022, reflecting a growth of approximately 1.0%[14] - The company's current assets totaled RMB 375,855,026.63, slightly down from RMB 379,454,266.08 at the end of 2022, indicating a decrease of about 0.8%[13] - Non-current assets increased to RMB 524,724,732.70 from RMB 512,273,562.57, representing a growth of approximately 2.8%[14] - The company's total liabilities decreased to RMB 224,628,063.07 from RMB 244,484,838.11, a reduction of about 8.1%[15] - The equity attributable to shareholders rose to RMB 641,377,844.75 from RMB 617,543,284.47, marking an increase of approximately 3.9%[15] - The company reported a decrease in short-term borrowings to RMB 49,043,100.00 from RMB 49,552,916.67, a decline of approximately 1.0%[15] - The company’s long-term investments increased to RMB 137,434,272.18 from RMB 99,798,720.98, representing a growth of approximately 37.7%[14] Inventory and Receivables - Accounts receivable decreased to RMB 140,865,947.60 from RMB 147,455,483.31, reflecting a decrease of approximately 4.5%[13] - Inventory increased to RMB 91,750,903.17 from RMB 77,423,153.84, indicating a growth of about 18.5%[13]
泛亚微透(688386) - 2023 Q3 - 季度财报